Deadline: 30-Jun-2026
The CMT Research Foundation Emerging Researcher Award supports early-career scientists and doctoral students worldwide to conduct innovative research advancing drug development for Charcot-Marie-Tooth (CMT) disease. The program funds projects that generate preliminary data, develop disease models, test drug delivery methods, or identify novel therapeutic targets.
This initiative fosters collaboration between academic, clinical, and industry researchers, providing Pilot and Predoctoral grants to accelerate progress toward new treatments.
Programme Focus
The award prioritizes research in areas critical to CMT therapeutic development, including:
- Understanding blood-nerve barrier dynamics and peripheral nerve cell types affected by CMT
- Testing new drug delivery technologies and methods for peripheral nervous system targeting
- Identifying or validating new therapeutics or molecular targets for individual or multiple CMT subtypes
- Developing improved disease models or preclinical tools to accelerate translation to human trials
Grant Types
1. Pilot Grant
- Funding: Up to $75,000 for one year
- Eligibility: Postdoctoral fellows or early-career investigators within 10 years of terminal degree
- Purpose: Support small-scale, high-impact projects generating preliminary data for larger research efforts
2. Predoctoral Grant
- Funding: Up to $25,000 for one year
- Eligibility: Doctoral students conducting research under mentorship
- Purpose: Support research with a clear pathway toward meaningful application and future development
Eligibility
- Open to researchers and clinicians worldwide
- Affiliations may include universities, academic medical centers, non-profits, or for-profit research organizations
- Biotech companies working on CMT therapeutics are encouraged, with funding subject to potential return if resulting IP achieves commercial success
- Projects must align with the mission to advance CMT drug development
Key Benefits
- Enables early-career investigators to establish research independence
- Generates preliminary data for larger grant applications or collaborative projects
- Encourages innovative and translational research for CMT therapeutics
- Supports academic-industry collaborations for drug development
Application Considerations
- Research should address high-impact, translational questions relevant to CMT treatment
- Proposals must demonstrate scientific rigor, innovation, and potential for future development
- Collaboration between academic and industry partners is encouraged to overcome key barriers in the field
Final Takeaway
The Emerging Researcher Award accelerates CMT drug development by funding innovative, small-scale projects led by early-career researchers and doctoral students. It cultivates scientific independence, collaborative networks, and translational research, ultimately contributing to the development of effective therapies for individuals affected by Charcot-Marie-Tooth disease.
For more information, visit CMT Research Foundation.